| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Bajaj SP | |
| Bajaj MS | |||
| P433 | issue | 1 | |
| P304 | page(s) | 471-477 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
| P1476 | title | Tissue factor pathway inhibitor: potential therapeutic applications | |
| P478 | volume | 78 |
| Q24794692 | Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis |
| Q35131040 | Microparticles in hemostasis and thrombosis. |
| Q36042279 | New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin |
| Q34893606 | Oral heparin: status review |
| Q25255548 | Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. |
| Q35963106 | Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor. |
| Q33359765 | Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation |
| Q28193706 | Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome) |
Search more.